Company: BNBX
Filing Date: 2025-02-11
Form Type: DEFA14A
Source: 0001104659-25-011231
Chunk: 2

Company: BNB PLUS CORP.
Filing Date: 2025-02-11
Form: DEFA14A
Chunk 2
---
1-646-491-9095 (call or text outside                                                                   
 North America) or by email at contactus@kingsdaleadvisors.com                                                                         |

Additional Information

In connection with the Company’s Special Meeting, the Company
has filed with the U.S. Securities and Exchange Commission (“SEC”) and mailed to the shareholders of record entitled to vote
at the Special Meeting a definitive proxy statement and other documents, including a proxy card. SHAREHOLDERS ARE ENCOURAGED TO READ THE
DEFINITIVE PROXY STATEMENT (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO) FILED BY THE COMPANY AND ALL OTHER RELEVANT DOCUMENTS WHEN
FILED WITH THE SEC AND WHEN THEY BECOME AVAILABLE BECAUSE THOSE DOCUMENTS WILL CONTAIN IMPORTANT INFORMATION. A copy of our Annual Report
on Form 10-K for the fiscal year ended September 30, 2024, including financial statements and any financial statement schedules
required to be filed in accordance with SEC rules, will be sent without charge to any stockholder of the Company requesting it in writing
from: Applied DNA Sciences, Inc., 50 Health Sciences Drive, Stony Brook, New York 11790, Attention: Beth Jantzen. We also make available,
free of charge on our website, all of our filings that are publicly filed on the SEC’s EDGAR website, including Forms 10-K, 10-Q
and 8-K, at www.adnas.com.

Investor Relations contact:Sanjay M. Hurry, 917-733-5573,
sanjay.hurry@adnas.com

Web: https://investors.adnas.com

X:@APDN

<div align='center'>###</div>